Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

MESOBLAST LTD (MESO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Final Director’s Interest Notice, Michael Spooner",
"Final Director’s Interest Notice, Michael Spooner"
07/31/2023 6-K Quarterly results
07/31/2023 F-6EF Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
07/31/2023 6-K Quarterly results
07/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"ABN 68 109 431 870 1.3",
"Appendix 3H of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
06/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Appendix 3Y of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
05/26/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"MESOBLAST REPORTS OPERATIONAL AND FINANCIAL HIGHLIGHTS FOR QUARTER ENDED MARCH 31, 2023",
"Investor presentation of Mesoblast Ltd"
05/18/2023 F-3 Form F-3 - Registration statement by foreign private issuers:
05/10/2023 SC 13G George Gregory reports a 7.4% stake in Mesoblast Limited
05/03/2023 6-K Quarterly results
04/04/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/04/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/24/2023 F-3 Form F-3 - Registration statement by foreign private issuers:
03/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"FDA SCHEDULES PRE-LICENSE INSPECTION OF REMESTEMCEL-L MANUFACTURING"
02/21/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"REMESTEMCEL-L CLINICAL AND POTENCY STUDIES PRESENTED AT PREMIER MEETING OF TRANSPLANTATION RESEARCH AND THERAPY"
02/01/2023 6-K Quarterly results
01/20/2023 SC 13G/A M&G INVESTMENT MANAGEMENT LTD reports a 12% stake in Mesoblast Limited
01/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
12/30/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/28/2022 6-K Quarterly results
12/27/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/20/2022 F-3 Form F-3 - Registration statement by foreign private issuers:
12/20/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Appendix 3G of Mesoblast Ltd",
"Appendix 3H of Mesoblast Ltd",
"Appendix 3Y of Mesoblast Ltd"
11/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"CHILDREN TREATED WITH REMESTEMCEL-L SHOW LONG-TERM SURVIVAL THROUGH FOUR YEARS IN STEROID-REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE",
"MESOBLAST REPORTS FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS FOR THE PERIOD ENDED SEPTEMBER 30, 2022",
"Presentation to Annual General Meeting",
"Chairman’s Annual General Meeting address",
"Results of Annual General Meeting"
11/28/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
11/16/2022 6-K Quarterly results
11/07/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Corporate Governance Statement and Appendix 4G of Mesoblast Ltd",
"Notice of Annual General Meeting of Mesoblast Ltd",
"Appendix 4C of Mesoblast Ltd"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy